Transforming alpha cells into insulin-producing beta cells for diabetes treatment
Alpha cell conversion to beta cells in non-human primates
This study is exploring a new way to help people with type 1 diabetes by turning certain cells in the pancreas into insulin-producing cells using a special virus, which could lead to a safer and more effective treatment without the need for immune-suppressing medications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10689993 on NIH RePORTER |
What this research studies
This research investigates a novel approach to treat type 1 diabetes by converting alpha cells in the pancreas into functioning beta cells using a viral delivery system. The method involves infusing an adeno-associated virus carrying specific genes into the pancreas, which has shown promising results in animal models. The goal is to create new beta cells from the patient's own tissues, potentially eliminating the need for immunosuppressive therapies. If successful, this could lead to a more effective and safer treatment for diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type 1 diabetes who are seeking innovative treatment options.
Not a fit: Patients with type 2 diabetes or those who do not have a functioning pancreas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a groundbreaking treatment for type 1 diabetes by enabling the regeneration of insulin-producing cells in patients.
How similar studies have performed: While similar approaches have shown promise in animal models, this specific method of converting alpha cells to beta cells in humans is novel and has not been widely tested.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Gittes, George K. — University of Pittsburgh at Pittsburgh
- Study coordinator: Gittes, George K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.